These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 34924021)

  • 1. Role of the lectin pathway of complement in hematopoietic stem cell transplantation-associated endothelial injury and thrombotic microangiopathy.
    Gavriilaki E; Ho VT; Schwaeble W; Dudler T; Daha M; Fujita T; Jodele S
    Exp Hematol Oncol; 2021 Dec; 10(1):57. PubMed ID: 34924021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compassionate Use Narsoplimab for Severe Refractory Transplantation-Associated Thrombotic Microangiopathy in Children.
    Schoettler ML; Patel S; Bryson E; Deeb L; Watkins B; Qayed M; Chandrakasan S; Fitch T; Silvis K; Jones J; Chonat S; Williams KM
    Transplant Cell Ther; 2024 Mar; 30(3):336.e1-336.e8. PubMed ID: 38145741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Lectin Pathway of the Complement System-Activation, Regulation, Disease Connections and Interplay with Other (Proteolytic) Systems.
    Dobó J; Kocsis A; Farkas B; Demeter F; Cervenak L; Gál P
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rare variants in complement system genes associate with endothelial damage after pediatric allogeneic hematopoietic stem cell transplantation.
    Leimi L; Koski JR; Kilpivaara O; Vettenranta K; Lokki AI; Meri S
    Front Immunol; 2023; 14():1249958. PubMed ID: 37771589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging Concepts in Hematopoietic Stem Cell Transplantation-Associated Renal Thrombotic Microangiopathy and Prospects for New Treatments.
    Wanchoo R; Bayer RL; Bassil C; Jhaveri KD
    Am J Kidney Dis; 2018 Dec; 72(6):857-865. PubMed ID: 30146419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A journey through the lectin pathway of complement-MBL and beyond.
    Garred P; Genster N; Pilely K; Bayarri-Olmos R; Rosbjerg A; Ma YJ; Skjoedt MO
    Immunol Rev; 2016 Nov; 274(1):74-97. PubMed ID: 27782323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Narsoplimab, a Mannan-Binding Lectin-Associated Serine Protease-2 Inhibitor, for the Treatment of Adult Hematopoietic Stem-Cell Transplantation-Associated Thrombotic Microangiopathy.
    Khaled SK; Claes K; Goh YT; Kwong YL; Leung N; Mendrek W; Nakamura R; Sathar J; Ng E; Nangia N; Whitaker S; Rambaldi A;
    J Clin Oncol; 2022 Aug; 40(22):2447-2457. PubMed ID: 35439028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic Susceptibility in Endothelial Injury Syndromes after Hematopoietic Cell Transplantation and Other Cellular Therapies: Climbing a Steep Hill.
    Evangelidis P; Evangelidis N; Kalmoukos P; Kourti M; Tragiannidis A; Gavriilaki E
    Curr Issues Mol Biol; 2024 May; 46(5):4787-4802. PubMed ID: 38785556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Complement Activating Collectins and Associated Serine Proteases in Patients With Hematological Malignancies, Receiving High-Dose Chemotherapy, and Autologous Hematopoietic Stem Cell Transplantations (Auto-HSCT).
    Świerzko AS; Michalski M; Sokołowska A; Nowicki M; Eppa Ł; Szala-Poździej A; Mitrus I; Szmigielska-Kapłon A; Sobczyk-Kruszelnicka M; Michalak K; Gołos A; Wierzbowska A; Giebel S; Jamroziak K; Kowalski ML; Brzezińska O; Thiel S; Jensenius JC; Kasperkiewicz K; Cedzyński M
    Front Immunol; 2018; 9():2153. PubMed ID: 30294330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early Increase in Complement Terminal Pathway Activation Marker sC5b-9 Is Predictive for the Development of Thrombotic Microangiopathy after Stem Cell Transplantation.
    Horváth O; Kállay K; Csuka D; Mező B; Sinkovits G; Kassa C; Stréhn A; Csordás K; Sinkó J; Prohászka Z; Kriván G
    Biol Blood Marrow Transplant; 2018 May; 24(5):989-996. PubMed ID: 29339271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-complexes of MASP-1 and MASP-2 associated with the soluble pattern-recognition molecules drive lectin pathway activation in a manner inhibitable by MAp44.
    Degn SE; Jensen L; Olszowski T; Jensenius JC; Thiel S
    J Immunol; 2013 Aug; 191(3):1334-45. PubMed ID: 23785123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial Dysfunction after Hematopoietic Stem Cell Transplantation: A Review Based on Physiopathology.
    Milone G; Bellofiore C; Leotta S; Milone GA; Cupri A; Duminuco A; Garibaldi B; Palumbo G
    J Clin Med; 2022 Jan; 11(3):. PubMed ID: 35160072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement System as a New Target for Hematopoietic Stem Cell Transplantation-Related Thrombotic Microangiopathy.
    Ardissino G; Capone V; Tedeschi S; Porcaro L; Cugno M
    Pharmaceuticals (Basel); 2022 Jul; 15(7):. PubMed ID: 35890144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The alternative complement pathway activation product Ba as a marker for transplant-associated thrombotic microangiopathy.
    Sartain S; Shubert S; Wu MF; Wang T; Martinez C
    Pediatr Blood Cancer; 2020 Mar; 67(3):e28070. PubMed ID: 31774252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MASP2 levels are elevated in thrombotic microangiopathies: association with microvascular endothelial cell injury and suppression by anti-MASP2 antibody narsoplimab.
    Elhadad S; Chapin J; Copertino D; Van Besien K; Ahamed J; Laurence J
    Clin Exp Immunol; 2021 Jan; 203(1):96-104. PubMed ID: 32681658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The emerging roles of mannose-binding lectin-associated serine proteases (MASPs) in the lectin pathway of complement and beyond.
    Dobó J; Pál G; Cervenak L; Gál P
    Immunol Rev; 2016 Nov; 274(1):98-111. PubMed ID: 27782318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormalities in the alternative pathway of complement in children with hematopoietic stem cell transplant-associated thrombotic microangiopathy.
    Jodele S; Licht C; Goebel J; Dixon BP; Zhang K; Sivakumaran TA; Davies SM; Pluthero FG; Lu L; Laskin BL
    Blood; 2013 Sep; 122(12):2003-7. PubMed ID: 23814021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Narsoplimab for severe transplant-associated thrombotic microangiopathy.
    Pandrowala A; Ganatra P; Krishnan VP; Sharma AN; Chavan S; Bodhanwala M; Agarwal B; Hiwarkar P
    Thromb J; 2023 Mar; 21(1):26. PubMed ID: 36915123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mannose-binding lectin (MBL)-associated serine protease (MASP)-1 contributes to activation of the lectin complement pathway.
    Takahashi M; Iwaki D; Kanno K; Ishida Y; Xiong J; Matsushita M; Endo Y; Miura S; Ishii N; Sugamura K; Fujita T
    J Immunol; 2008 May; 180(9):6132-8. PubMed ID: 18424734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombotic microangiopathy mediates poor prognosis among lupus nephritis
    Zhang B; Xing G
    Front Immunol; 2022; 13():1081942. PubMed ID: 36582241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.